CVRx, Inc.
NASDAQ:CVRXMedical - Devices
Healthcare
$2.63 +2.28%
+$0.11 today
- Market cap
- $69.79M
- Beta
- 0.77
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$2.00
52W Low $4.37High $11.30
Volume 0.37M
Average 0.30M
Income Statement
Follow revenue through to earnings.
Revenue
$56.65M
FY 2025 · Annual
+10.4% YoYOperating Income
-$51.27M
FY 2025 · Annual
Net Income
-$53.31M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.04M | 22.47M | 39.3M | 51.29M | 56.65M |
| Cost of Revenue | 3.64M | 5M | 6.26M | 8.33M | 8.31M |
| Gross Profit | 9.4M | 17.47M | 33.04M | 42.96M | 48.34M |
| Gross Margin | 72.1% | 77.8% | 84.1% | 83.8% | 85.3% |
| Research & Development | 7.5M | 9.95M | 11.63M | 11.13M | 11.13M |
| Selling, General & Admin | 27.86M | 50.05M | 64.51M | 91.32M | 88.47M |
| Operating Expenses | 35.36M | 60M | 76.14M | 102.45M | 99.61M |
| Depreciation & Amortization | 168K | 412K | 522K | 619K | 756K |
| EBITDA | (40.6M) | (40.74M) | (38.73M) | (54.89M) | (46.74M) |
| EBITDA Margin | -311.4% | -181.3% | -98.6% | -107.0% | -82.5% |
| Operating Income | (25.97M) | (42.53M) | (43.1M) | (59.49M) | (51.27M) |
| Operating Margin | -199.2% | -189.3% | -109.7% | -116.0% | -90.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.22M | 165K | 1.8M | 4.4M | 5.83M |
| Other Income / Expenses | (17.02M) | 1.21M | 2.05M | (420K) | (2.06M) |
| Income Before Tax | (42.99M) | (41.32M) | (41.05M) | (59.91M) | (53.32M) |
| Pre-Tax Margin | -329.8% | -183.9% | -104.5% | -116.8% | -94.1% |
| Income Tax Expense | 91K | 109K | 147K | 55K | (18K) |
| Net Income | (43.08M) | (41.43M) | (41.2M) | (59.97M) | (53.31M) |
| Net Margin | -330.5% | -184.4% | -104.8% | -116.9% | -94.1% |
| EPS (Basic) | (2.11) | (2.02) | (1.99) | (2.65) | (2.04) |
| EPS (Diluted) | (2.11) | (2.02) | (1.99) | (2.65) | (2.04) |
| 20.72M | 20.51M | 20.7M | 22.6M | 26.08M | |
| 20.72M | 20.53M | 20.75M | 22.6M | 26.08M |
CVRX Earnings Waterfall · TTM
NASDAQ:CVRX · Revenue to Net Income
Key Ratios
EPS$-2.02
Gross Margin85.5%
Net Margin-89.8%
P/E Ratio-3.8
P/S Ratio13.5
Analysis
$59.1M of revenue converted into -$52.7M of net income for the selected period. Gross margin is 85.5% and net margin is -89.8%, showing how much revenue survives after costs and taxes. EPS is $-2.02, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Sep 21, 2026 | |
| SC 13D | SC 13D filing | Aug 24, 2026 | |
| SC 13G | SC 13G filing | Aug 14, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 13, 2026 |
How much revenue does CVRX generate?
CVRx, Inc. (CVRX) reported $56.65M of revenue in fiscal 2025.
Is CVRX profitable?
CVRx, Inc. (CVRX) reported -$53.31M of net income, with a net margin of -94.1%.
Continue the stock analysis
Jump to another research area for this company.